Histogen   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2007)

Organization Overview

First Clinical Trial
2018
NCT03662854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Histogen